BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 1929745)

  • 1. [Congenital hypothyroidism. Therapeutic strategy at the early stage of treatment].
    Touati G; Léger J; Czernichow P
    Arch Fr Pediatr; 1991; 48(7):461-5. PubMed ID: 1929745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IGF-1 and IGFBP in congenital and acquired hypothyroidism after long-term replacement treatment.
    Bona G; Rapa A; Boccardo G; Silvestro L; Chiorboli E
    Minerva Endocrinol; 1999 Jun; 24(2):51-5. PubMed ID: 10941423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Replacement therapy with levothyroxine plus triiodothyronine (bioavailable molar ratio 14 : 1) is not superior to thyroxine alone to improve well-being and cognitive performance in hypothyroidism.
    Siegmund W; Spieker K; Weike AI; Giessmann T; Modess C; Dabers T; Kirsch G; Sänger E; Engel G; Hamm AO; Nauck M; Meng W
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):750-7. PubMed ID: 15163340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel therapeutic paradigm to treat congenital hypothyroidism.
    Mathai S; Cutfield WS; Gunn AJ; Webster D; Jefferies C; Robinson E; Hofman P
    Clin Endocrinol (Oxf); 2008 Jul; 69(1):142-7. PubMed ID: 18598275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hormonal therapy of congenital hypothyroidism in childhood].
    Rondanini GF; Focarile F; Bollati A; Bianchi C
    Pediatr Med Chir; 1983; 5(6):473-6. PubMed ID: 6681055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamics of the plasma concentrations of TSH, FT4 and T3 following thyroxine supplementation in congenital hypothyroidism.
    Bakker B; Kempers MJ; De Vijlder JJ; Van Tijn DA; Wiedijk BM; Van Bruggen M; Vulsma T
    Clin Endocrinol (Oxf); 2002 Oct; 57(4):529-37. PubMed ID: 12354136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of evening vs morning thyroxine ingestion on serum thyroid hormone profiles in hypothyroid patients.
    Bolk N; Visser TJ; Kalsbeek A; van Domburg RT; Berghout A
    Clin Endocrinol (Oxf); 2007 Jan; 66(1):43-8. PubMed ID: 17201800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initial treatment dose of L-thyroxine in congenital hypothyroidism.
    Selva KA; Mandel SH; Rien L; Sesser D; Miyahira R; Skeels M; Nelson JC; Lafranchi SH
    J Pediatr; 2002 Dec; 141(6):786-92. PubMed ID: 12461494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Twenty-four hour hormone profiles of TSH, Free T3 and free T4 in hypothyroid patients on combined T3/T4 therapy.
    Saravanan P; Siddique H; Simmons DJ; Greenwood R; Dayan CM
    Exp Clin Endocrinol Diabetes; 2007 Apr; 115(4):261-7. PubMed ID: 17479444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of L-thyroxine replacement therapy in children with congenital hypothyroidism.
    Chiovato L; Giusti L; Tonacchera M; Ciampi M; Mammoli C; Lippi F; Lapi P; Bargagna S; Dini P; Ferretti G
    J Endocrinol Invest; 1991 Dec; 14(11):957-64. PubMed ID: 1806614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A thyroxine dosage of 8 micrograms/kg per day is appropriate for the initial treatment of the majority of infants with congenital hypothyroidism.
    Touati G; Léger J; Toublanc JE; Farriaux JP; Stuckens C; Ponte C; David M; Rochiccioli P; Porquet D; Czernichow P
    Eur J Pediatr; 1997 Feb; 156(2):94-8. PubMed ID: 9039509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IGF-1 and IGFBP-3 in congenital and acquired hypothyroidism after long-term replacement treatment.
    Bona G; Rapa A; Boccardo G; Silvestro L; Chiorboli E
    Panminerva Med; 1998 Jun; 40(2):103-6. PubMed ID: 9689829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The utility of FT4 serum in newborns at risk for congenital hypothyroidism (CH).
    Cordova RA; Vignola G
    Southeast Asian J Trop Med Public Health; 2003; 34 Suppl 3():152-3. PubMed ID: 15906723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Alpha fetoprotein in congenital hypothyroidism before and during treatment].
    Toublanc JE; Ingrand J; Megarbane M; Fulla Y; Rives S
    Arch Pediatr; 1994 Oct; 1(10):872-8. PubMed ID: 7531094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Value of the ultrasensitive assay of plasma TSH for the surveillance of replacement treatment in children with congenital hypothyroidism].
    Raux Demay MC; Silvain A; Girard F
    Arch Fr Pediatr; 1988 Oct; 45(8):549-52. PubMed ID: 3214248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of high versus low initial doses of L-thyroxine for congenital hypothyroidism on thyroid function and somatic growth.
    Jones JH; Gellén B; Paterson WF; Beaton S; Donaldson MD
    Arch Dis Child; 2008 Nov; 93(11):940-4. PubMed ID: 18456702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of the parameters used in monitoring hypothyroid patients treated with L-thyroxine].
    Custro N; Scafidi V; Indovina I
    Minerva Med; 1986 Dec; 77(47-48):2227-33. PubMed ID: 3101002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of perinatal asphyxia on thyroid-stimulating hormone and thyroid hormone levels.
    Pereira DN; Procianoy RS
    Acta Paediatr; 2003; 92(3):339-45. PubMed ID: 12725550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A study of L-thyroxine replacement.
    Burnett JR; Cooke R; Crooke MJ; Feek CM
    N Z Med J; 1992 Mar; 105(930):105-6. PubMed ID: 1553113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Head circumference and linear growth during the first 3 years in treated congenital hypothyroidism in relation to aetiology and initial biochemical severity.
    Ng SM; Wong SC; Didi M
    Clin Endocrinol (Oxf); 2004 Jul; 61(1):155-9. PubMed ID: 15212659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.